{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:02:14Z","timestamp":1790359334424,"version":"4.1.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Statistical work was funded by Asacpharma"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>People with gout exhibit significant clinical heterogeneity due to diverse comorbidity profiles. This study aimed to identify distinct clinical phenotypes using cluster analysis and to evaluate differences in management, specifically urate-lowering therapy (ULT) patterns and sustained serum urate (SU) control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A population-based retrospective cohort study was conducted using the SIDIAP database (Catalonia, Spain), including 94\u00a0759 patients with incident gout (2012\u201323). A K-prototypes algorithm identified clusters based on demographics and major comorbidities. Outcomes included sustained SU control (defined as SU &amp;lt;6\u2009mg\/dl for \u226580% of the follow-up time) and ULT adherence (Medication Possession Ratio).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Three distinct clusters were identified. Cluster 1 (37.0%) was comprised of younger patients (mean age 54) with fewer comorbidities and the highest SU control. Cluster 2 (22.8%) included older patients (mean age 74) characterized by 100% type 2 diabetes prevalence, high obesity (51.3%), and the greatest cardiovascular burden. Cluster 3 (40.2%) featured older patients with hypertension and dyslipidaemia but no diabetes. Overall, management was suboptimal in all groups; only 12% of patients achieved sustained SU control. While Cluster 2 had higher ULT prescription rates, Cluster 1 showed better adherence and SU control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Gout manifests in three clearly differentiated clinical phenotypes, each potentially reflecting a distinct predominant aetiology of hyperuricaemia (isolated\/genetic, insulin-resistance-mediated, or renal-vascular). The identification of these high-risk metabolic and hypertensive clusters underscores the need for comorbidity-driven management and tailored therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keag415","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T11:46:39Z","timestamp":1786535199000},"source":"Crossref","is-referenced-by-count":0,"title":["Isolated, metabolic and hypertensive gout: a population-based cluster analysis of 94\u00a0759 patients"],"prefix":"10.1093","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5792-2802","authenticated-orcid":false,"given":"Maria Antonia","family":"Pou","sequence":"first","affiliation":[{"name":"Department of Medicine, Universitat Aut\u00f2noma de Barcelona , Barcelona,","place":["Spain"]},{"name":"Equip d\u2019Atenci\u00f3 Prim\u00e0ria Encants, ICS , Barcelona,","place":["Spain"]},{"name":"Grup de Recerca en Malalties Prevalents de l\u2019Aparell Locomotor (GREMPAL), IDIAP Jordi Gol, ICS , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5374-8176","authenticated-orcid":false,"given":"Daniel","family":"Martinez-Laguna","sequence":"additional","affiliation":[{"name":"Grup de Recerca en Malalties Prevalents de l\u2019Aparell Locomotor (GREMPAL), IDIAP Jordi Gol, ICS , Barcelona,","place":["Spain"]},{"name":"Centre d'Atenci\u00f3 Prim\u00e0ria Sant Mart\u00ed, ICS , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8486-3265","authenticated-orcid":false,"given":"Carlen","family":"Reyes","sequence":"additional","affiliation":[{"name":"Grup de Recerca en Malalties Prevalents de l\u2019Aparell Locomotor (GREMPAL), IDIAP Jordi Gol, ICS , Barcelona,","place":["Spain"]},{"name":"Unitat de Recerca Equip d\u2019Atenci\u00f3 Prim\u00e0ria Barcelona Sardenya-Institut de Recerca Sant Pau , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8144-4089","authenticated-orcid":false,"given":"Pau","family":"Satorra","sequence":"additional","affiliation":[{"name":"Biostatistics Support and Research Unit, Germans Trias i Pujol Research Institute and Hospital (IGTP) , Badalona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2320-1385","authenticated-orcid":false,"given":"Cristian","family":"Teb\u00e9","sequence":"additional","affiliation":[{"name":"Biostatistics Support and Research Unit, Germans Trias i Pujol Research Institute and Hospital (IGTP) , Badalona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7738-6787","authenticated-orcid":false,"given":"Hector","family":"Corominas","sequence":"additional","affiliation":[{"name":"Department of Medicine, Universitat Aut\u00f2noma de Barcelona , Barcelona,","place":["Spain"]},{"name":"Servei de Reumatologia, Hospital de la Santa Creu i Sant Pau , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4632-4476","authenticated-orcid":false,"given":"Nicola","family":"Dalbeth","sequence":"additional","affiliation":[{"name":"University of Auckland, Department of Medicine,","place":["New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6275-7699","authenticated-orcid":false,"given":"Cesar","family":"Diaz-Torne","sequence":"additional","affiliation":[{"name":"Department of Medicine, Universitat Aut\u00f2noma de Barcelona , Barcelona,","place":["Spain"]},{"name":"Grup de Recerca en Malalties Prevalents de l\u2019Aparell Locomotor (GREMPAL), IDIAP Jordi Gol, ICS , Barcelona,","place":["Spain"]},{"name":"Servei de Reumatologia, Hospital de la Santa Creu i Sant Pau , Barcelona,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"2026092513474389100_keag415-B1","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet"},{"key":"2026092513474389100_keag415-B2","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1016\/S2665-9913(24)00117-6","article-title":"Global, regional, and national burden of gout and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"6","author":"Cross","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"2026092513474389100_keag415-B3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2026092513474389100_keag415-B4","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.ard.2025.08.002","article-title":"The impact of population ageing on musculoskeletal disorders in 204 countries and territories, 1990-2021: global burden and healthcare costs","volume":"84","author":"Guan","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"2026092513474389100_keag415-B5","doi-asserted-by":"crossref","first-page":"152273","DOI":"10.1016\/j.semarthrit.2023.152273","article-title":"All-cause and specific mortality in patients with gout: a systematic review and meta-analysis","volume":"63","author":"Wang","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"2026092513474389100_keag415-B6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12916-017-0922-5","article-title":"What makes gouty inflammation so variable?","volume":"15","author":"Terkeltaub","year":"2017","journal-title":"BMC Med"},{"key":"2026092513474389100_keag415-B7","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1038\/s41588-024-01921-5","article-title":"A genome-wide association analysis reveals new pathogenic pathways in gout","volume":"56","author":"Major","year":"2024","journal-title":"Nat Genet"},{"key":"2026092513474389100_keag415-B8","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/rheumatology\/key096","article-title":"Comorbidity clusters in people with gout: an observational cohort study with linked medical record review","volume":"57","author":"Bevis","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2026092513474389100_keag415-B9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/annrheumdis-2013-203779","article-title":"Revisiting comorbidities in gout: a cluster analysis","volume":"74","author":"Richette","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2026092513474389100_keag415-B10","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s40618-023-02224-y","article-title":"Clustering of gout-related comorbidities and their relationship with gout flares: a data-driven cluster analysis of eight comorbidities","volume":"47","author":"Liu","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"2026092513474389100_keag415-B11","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3899\/jrheum.220635","article-title":"Clustering patients with gout based on comorbidities and biomarkers: a cross-sectional study","volume":"50","author":"Alduraibi","year":"2023","journal-title":"J Rheumatol"},{"key":"2026092513474389100_keag415-B12","first-page":"135","article-title":"Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP)","volume":"19","author":"Garc\u00eda-Gil","year":"2011","journal-title":"Inform Prim Care"},{"key":"2026092513474389100_keag415-B13","doi-asserted-by":"crossref","first-page":"105628","DOI":"10.1016\/j.jbspin.2023.105628","article-title":"Validation of gout diagnosis in electronic primary care medical records: a population-based study","volume":"90","author":"Pou","year":"2023","journal-title":"Joint Bone Spine"},{"key":"2026092513474389100_keag415-B14","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.3390\/ijerph17134672","article-title":"Socioeconomic inequalities in mortality among foreign-born and Spanish-born in small areas in cities of the Mediterranean Coast in Spain, 2009\u20132015","volume":"17","author":"Oliva-Arocas","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"2026092513474389100_keag415-B15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","article-title":"Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study","volume":"74","author":"Kuo","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2026092513474389100_keag415-B16","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/annrheumdis-2011-200801","article-title":"Patient and provider barriers to effective management of gout in general practice: a qualitative study","volume":"71","author":"Spencer","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2026092513474389100_keag415-B17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1023\/A:1009769707641","article-title":"Extensions to the k-means algorithm for clustering large data sets with categorical values","volume":"2","author":"Huang","year":"1998","journal-title":"Data Min Knowl Discov"},{"key":"2026092513474389100_keag415-B18","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/acr.23347","article-title":"Dyslipidemia, alcohol consumption, and obesity as main factors associated with poor control of urate levels in patients receiving urate-lowering therapy","volume":"70","author":"Latourte","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026092513474389100_keag415-B19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jbspin.2017.03.013","article-title":"Persistent clinical inertia in gout in 2014: an observational French longitudinal patient database study","volume":"85","author":"Maravic","year":"2018","journal-title":"Joint Bone Spine"},{"key":"2026092513474389100_keag415-B20","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/ijcp.12604","article-title":"Allopurinol adherence among patients with gout: an Italian general practice database study","volume":"69","author":"Mantarro","year":"2015","journal-title":"Int J Clin Pract"},{"key":"2026092513474389100_keag415-B21","doi-asserted-by":"crossref","first-page":"100416","DOI":"10.1016\/j.lanepe.2022.100416","article-title":"Management of gout following 2016\/2017 European (EULAR) and British (BSR) guidelines: an interrupted time-series analysis in the United Kingdom","volume":"18","author":"Russell","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"2026092513474389100_keag415-B22","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/acr.25380","article-title":"Adherence and treat-to-target benchmarks in older adults with gout initiating urate-lowering therapy in Ontario, Canada: a population-based study","volume":"76","author":"Kwok","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026092513474389100_keag415-B23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3899\/jrheum.190522","article-title":"Factors influencing the effectiveness of allopurinol in achieving and sustaining target serum urate in a US Veterans Affairs gout cohort","volume":"47","author":"Singh","year":"2020","journal-title":"J Rheumatol"},{"key":"2026092513474389100_keag415-B24","doi-asserted-by":"crossref","first-page":"102897","DOI":"10.1016\/j.dsx.2023.102897","article-title":"Unsupervised cluster analysis of clinical and ultrasound features reveals unique gout subtypes: results from the Egyptian College of Rheumatology (ECR)","volume":"17","author":"Hammam","year":"2023","journal-title":"Diabetes Metab Syndr"},{"key":"2026092513474389100_keag415-B25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41584-024-01137-1","article-title":"The pathogenesis of gout: molecular insights from genetic, epigenomic and transcriptomic studies","volume":"20","author":"Leask","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"2026092513474389100_keag415-B26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13075-021-02444-8","article-title":"The comparative effect of exposure to various risk factors on the risk of hyperuricaemia: diet has a weak causal effect","volume":"23","author":"Topless","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"2026092513474389100_keag415-B27","doi-asserted-by":"crossref","first-page":"10185","DOI":"10.1038\/s41598-023-37274-y","article-title":"Prevalence and influencing factors of hyperuricemia in middle-aged and older adults in the Yao minority area of China: a cross-sectional study","volume":"13","author":"Lyu","year":"2023","journal-title":"Sci Rep"},{"key":"2026092513474389100_keag415-B28","doi-asserted-by":"crossref","first-page":"k3951","DOI":"10.1136\/bmj.k3951","article-title":"Evaluation of the diet wide contribution to serum urate levels: meta-analysis of population based cohorts","volume":"363","author":"Major","year":"2018","journal-title":"BMJ"},{"key":"2026092513474389100_keag415-B29","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1001\/jama.1991.03470210076036","article-title":"Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration","volume":"266","author":"Facchini","year":"1991","journal-title":"JAMA"},{"key":"2026092513474389100_keag415-B30","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186633","article-title":"Gene-environment interaction modifies the association between hyperinsulinemia and serum urate levels through SLC22A12","volume":"135","author":"Fujii","year":"2025","journal-title":"J Clin Invest"},{"key":"2026092513474389100_keag415-B31","first-page":"364","article-title":"Evaluation of renal handling of uric acid in essential hypertension: hyperuricemia related to decreased urate secretion","volume":"59","author":"Tykarski","year":"1991","journal-title":"Nephron"},{"key":"2026092513474389100_keag415-B32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2147\/VHRM.S61363","article-title":"Serum uric acid and target organ damage in essential hypertension","volume":"10","author":"Ofori","year":"2014","journal-title":"Vasc Health Risk Manag"},{"key":"2026092513474389100_keag415-B33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2474-12-103","article-title":"Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population","volume":"12","author":"Primatesta","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"key":"2026092513474389100_keag415-B34","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1093\/rheumatology\/keaf136","article-title":"Gout incidence in metformin versus sodium\u2013glucose co-transporter-2 inhibitor users: a retrospective cohort study","volume":"64","author":"Hatano","year":"2025","journal-title":"Rheumatology"},{"key":"2026092513474389100_keag415-B35","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1186\/s12872-025-05339-7","article-title":"Antihypertensive drugs for hyperuricemia in patients with hypertension: a systematic review and network meta-analysis of Chinese trials","volume":"25","author":"Wu","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"2026092513474389100_keag415-B36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/gucdd2020014","article-title":"SGLT2 inhibitors and uric acid homeostasis","volume":"2","author":"Zapf","year":"2024","journal-title":"Gout Urate Crystal Depos Dis"},{"key":"2026092513474389100_keag415-B37","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/gucdd2020013","article-title":"Gout and gout-related comorbidities: insight and limitations from population-based registers in Sweden","volume":"2","author":"Drivelegka","year":"2024","journal-title":"Gout, Urate, Crystal Depos Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keag415\/70622221\/keag415.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/9\/keag415\/70622221\/keag415.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/9\/keag415\/70622221\/keag415.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:47:52Z","timestamp":1790358472000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keag415\/8759989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keag415","relation":{},"ISSN":["1462-0332"],"issn-type":[{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,8,12]]},"article-number":"keag415"}}